Loading clinical trials...
Loading clinical trials...
Assessment of the Aerobic Capacity of (Well-trained) Transgender Women Athletes Submitted to the Maximal Exercise Test: a Prospective Cohort.
The study will evaluate the sports capabilities of transgender women mainly in terms of muscular strength and aerobic capacity (VO2max). The control group will be composed of cisgender women and cisgender men with the same levels of physical activity.
Age
18 - 50 years
Sex
ALL
Healthy Volunteers
Yes
Start Date
May 1, 2022
Primary Completion Date
August 1, 2022
Completion Date
June 1, 2023
Last Updated
April 20, 2022
60
ESTIMATED participants
Aerobic exercise test.
OTHER
Lead Sponsor
Instituto Brasileiro de Controle do Cancer
NCT06177600
NCT06487754
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions